0
Curbing China’s Vaccine Diplomacy Act
12/31/2022, 5:07 AM
Summary of Bill HR 4362
The main provisions of the bill include increasing transparency and accountability in the distribution of vaccines by requiring the US government to report on China's vaccine diplomacy efforts. It also calls for the establishment of a task force to monitor and assess China's vaccine diplomacy activities and their impact on global health security.
Additionally, the bill aims to strengthen US leadership in global health by promoting the development and distribution of safe and effective vaccines. It calls for increased funding for international vaccine initiatives and partnerships to ensure that the US remains a key player in the global vaccine market. Overall, the Curbing China's Vaccine Diplomacy Act is a response to China's growing influence in the global vaccine market and seeks to protect US interests and promote global health security.
Congressional Summary of HR 4362
Curbing China's Vaccine Diplomacy Act
This bill requires the Department of State, in carrying out the international distribution of COVID-19 vaccine doses, to prioritize distribution to and ensure that at least 25% of such doses are reserved for Taiwan and certain Latin American allies.
The State Department may not make such distribution until the Administration determines that all Americans have been afforded ample opportunity to be vaccinated against COVID-19. Further, the State Department must ensure that at least 25% of COVID-19 vaccine doses intended for international distribution are reserved for and distributed to Taiwan and Latin American allies, and it may not distribute any doses internationally to any recipient or country until Taiwan and Latin American allies receive their first shipment of such doses.



